2,1,3-benzothiadiazol-4-ylboronic acid

Modify Date: 2025-08-27 09:45:50

2,1,3-benzothiadiazol-4-ylboronic acid Structure
2,1,3-benzothiadiazol-4-ylboronic acid structure
Common Name 2,1,3-benzothiadiazol-4-ylboronic acid
CAS Number 499769-94-7 Molecular Weight 179.99200
Density 1.53 g/cm3 Boiling Point 383.1ºC at 760 mmHg
Molecular Formula C6H5BN2O2S Melting Point 166.3ºC
MSDS N/A Flash Point 185.5ºC

 Names

Name 2,1,3-benzothiadiazol-4-ylboronic acid
Synonym More Synonyms

 Chemical & Physical Properties

Density 1.53 g/cm3
Boiling Point 383.1ºC at 760 mmHg
Melting Point 166.3ºC
Molecular Formula C6H5BN2O2S
Molecular Weight 179.99200
Flash Point 185.5ºC
Exact Mass 180.01600
PSA 94.48000

 MSDS

Name: 2 1 3-Benzothiadiazol-4-ylboronic acid 97% Material Safety Data Sheet
Synonym:
CAS: 499769-94-7
Section 1 - Chemical Product MSDS Name:2 1 3-Benzothiadiazol-4-ylboronic acid 97% Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
499769-94-7 2,1,3-Benzothiadiazol-4-ylboronic acid 97% unlisted
Hazard Symbols: XI
Risk Phrases: 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Keep refrigerated. (Store below 4C/39F.) Store in a tightly closed container. Store in a dry area.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 499769-94-7: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 166.3 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C6H5BN2O2S
Molecular Weight: 180

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide, oxides of boron.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 499769-94-7 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2,1,3-Benzothiadiazol-4-ylboronic acid - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 499769-94-7: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 499769-94-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 499769-94-7 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

 Safety Information

Hazard Codes Xi:Irritant;
Risk Phrases R36/37/38
Safety Phrases S26-S37/39

 Synonyms

Benzo-2,1,3-thiadiazole-4-boronic acid
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here
Related Compounds: More...
2,1,3-benzothiadiazol-5-ylboronic acid
191341-04-5
[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino](phenyl)acetic acid
327169-27-7
[(2,1,3-benzothiadiazol-4-ylsulfonyl)(methyl)amino]acetic acid
899718-18-4
4-[(2,1,3-Benzothiadiazol-4-ylsulfonyl)amino]butanoic acid
405279-58-5
Ethyl 2,1,3-benzothiadiazol-4-ylcarbamate
71014-12-5
4-{[(2,1,3-benzothiadiazol-4-ylsulfonyl)amino]methyl}cyclohexanecarboxylic acid
899721-22-3
1-(2,1,3-Benzothiadiazol-4-ylsulfonyl)piperidine-4-carboxylic acid
488090-09-1
bis[2-[2,1,3-benzothiadiazol-4-yl(methyl)amino]ethylsulfanyl]methanethione
71605-60-2
1-[(7-methyl-2,1,3-benzothiadiazol-4-yl)sulfonyl]piperidine-4-carboxylic acid
6048-07-3
2,4-Dimethyl-2-(propan-2-yloxy)pentan-1-amine
1598558-82-7
2-Methyl-2-(propan-2-yloxy)pentan-1-amine
1593989-46-8
2-(Propan-2-yloxy)heptan-1-amine
1594013-98-5
2,3-Dimethyl-2-(propan-2-yloxy)pentan-1-amine
1592284-09-7
2-(Piperidin-3-yl)benzene-1,4-diol
1260782-13-5
2-[3-[6-Amino-5-[2-(methylamino)ethoxy]pyrimidin-4-yl]-5-fluoro-2-(hydroxymethyl)phenyl]-6-cyclopropyl-3,4-dihydroisoquinolin-1-one
1787294-68-1
2-(3-(6-Amino-5-(2-(methylamino)ethoxy)pyrimidin-4-yl)phenyl)-6-cyclopropyl-8-fluoroisoquinolin-1(2H)-one
1787294-58-9
N-(3-(6-Amino-5-(2-(methylamino)ethoxy)pyrimidin-4-yl)-5-fluoro-2-methylphenyl)-4-cyclopropyl-2-fluorobenzamide
1787294-53-4
Ethyl 6-methyl-4-(2-nitrophenyl)-2-(thiazol-2-yl)-1,4-dihydropyrimidine-5-carboxylate
1571211-70-5
3-((1,6-Naphthyridin-4-yl)methyl)-2-oxa-8-azaspiro[4.5]decane
1442091-69-1